411 related articles for article (PubMed ID: 23226051)
1. Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy.
Li J; Bluth MH
Pharmgenomics Pers Med; 2011; 4():11-33. PubMed ID: 23226051
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
Bosch TM
Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
Ahmed S; Zhou Z; Zhou J; Chen SQ
Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):298-313. PubMed ID: 27729266
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacogenetics and potential application in personalized medicine.
Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
[TBL] [Abstract][Full Text] [Related]
5. [Personalized dosing from perspective of pharmacogenomics of drug metabolizing enzymes and transporters].
Zhou Q; Yu LS; Zeng S
Yao Xue Xue Bao; 2017 Jan; 52(1):1-7. PubMed ID: 29911367
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics: the inherited basis for interindividual differences in drug response.
Evans WE; Johnson JA
Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642
[TBL] [Abstract][Full Text] [Related]
7. Is personalized medicine a dream or a reality?
Morse BL; Kim RB
Crit Rev Clin Lab Sci; 2015 Feb; 52(1):1-11. PubMed ID: 25181036
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives.
Arbitrio M; Di Martino MT; Scionti F; Barbieri V; Pensabene L; Tagliaferri P
High Throughput; 2018 Dec; 7(4):. PubMed ID: 30567415
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine.
Avery P; Mousa SS; Mousa SA
Pharmgenomics Pers Med; 2009; 2():79-91. PubMed ID: 23226037
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of MDR and MRP subfamilies.
Okamura N; Sakaeda T; Okumura K
Per Med; 2004 Dec; 1(1):85-104. PubMed ID: 29793230
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics for the forensic toxicologist.
Kupiec TC; Raj V; Vu N
J Anal Toxicol; 2006 Mar; 30(2):65-72. PubMed ID: 16620540
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics in drug-metabolizing enzymes catalyzing anticancer drugs for personalized cancer chemotherapy.
Fujita K; Sasaki Y
Curr Drug Metab; 2007 Aug; 8(6):554-62. PubMed ID: 17691917
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs.
Urquhart BL; Tirona RG; Kim RB
J Clin Pharmacol; 2007 May; 47(5):566-78. PubMed ID: 17442683
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics and renal drug disposition in the newborn.
Kapur G; Mattoo T; Aranda JV
Semin Perinatol; 2004 Apr; 28(2):132-40. PubMed ID: 15200252
[TBL] [Abstract][Full Text] [Related]
15. Challenges in current drug delivery from the potential application of pharmacogenomics and personalized medicine in clinical practice.
Vizirianakis IS
Curr Drug Deliv; 2004 Jan; 1(1):73-80. PubMed ID: 16305372
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.
Mango R; Vecchione L; Raso B; Borgiani P; Brunetti E; Mehta JL; Lauro R; Romeo F; Novelli G
Expert Opin Pharmacother; 2005 Dec; 6(15):2565-76. PubMed ID: 16316297
[TBL] [Abstract][Full Text] [Related]
17. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
Lee W; Lockhart AC; Kim RB; Rothenberg ML
Oncologist; 2005 Feb; 10(2):104-11. PubMed ID: 15709212
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy.
Evans WE
Ther Drug Monit; 2004 Apr; 26(2):186-91. PubMed ID: 15228163
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy.
Ieiri I; Takane H; Hirota T; Otsubo K; Higuchi S
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):651-74. PubMed ID: 17014387
[TBL] [Abstract][Full Text] [Related]
20. Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model.
Goetz MP; Ames MM; Weinshilboum RM
Mayo Clin Proc; 2004 Mar; 79(3):376-84. PubMed ID: 15008610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
